Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GDP-beta-L-fucose + 2-nitrophenyl beta-D-galactopyranoside
GDP + 2-nitrophenyl alpha-L-fucosyl-(1->2)-beta-D-galactopyranoside
-
-
-
-
?
GDP-beta-L-fucose + beta-D-galactose
?
-
-
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosamine
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosamine
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine
GDP-beta-L-fucose + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-galactosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-galactosamine
residues of H type 3 epitopes, reaction of EC 2.4.1.69
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
residues of H type 2 epitopes
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine
-
i.e. N-acetyllactosamine, reaction of EC 2.4.1.344
-
-
?
GDP-beta-L-fucose + D-Gal-beta-(1,2)-D-Glc-beta-O-methyl
GDP + L-Fuc-alpha-(1,2)-D-Gal-beta-(1,2)-D-Glc-beta-O-methyl
-
-
-
-
?
GDP-beta-L-fucose + D-Gal-beta-(1,4)-D-Glc-beta-O-methyl
GDP + L-Fuc-alpha-(1,2)-D-Gal-beta-(1,4)-D-Glc-beta-O-methyl
-
-
-
-
?
GDP-beta-L-fucose + D-Gal-beta-(1,6)-D-Glc-beta-O-methyl
GDP + L-Fuc-alpha-(1,2)-D-Gal-beta-(1,6)-D-Glc-beta-O-methyl
-
-
-
-
?
GDP-beta-L-fucose + D-Gal-beta-(1->3)-D-Glcbeta-O-methyl
GDP + L-Fuc-alpha-(1->2)-D-Gal-beta-(1->3)-D-Glc-beta-O-methyl
-
-
-
-
?
GDP-beta-L-fucose + D-galactose
?
GDP-beta-L-fucose + D-lactose
GDP + 2'-fucosyl-D-lactose
GDP-beta-L-fucose + D-lactulose
GDP + 2'-fucosyl-D-lactulose
GDP-beta-L-fucose + Gal(beta1-3)GlcNAc
?
28% activity compared to D-lactose
-
-
?
GDP-beta-L-fucose + Gal(beta1-4)GlcNAc
?
85% activity compared to D-lactose
-
-
?
GDP-beta-L-fucose + Gal-beta-OR
GDP + L-Fucalpha(1-2)Galbeta-OR
GDP-beta-L-fucose + galactose
GDP + ?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1,3)GalNAcalpha-O-Me
GDP + ?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1,3)GalNAcalpha-O-phenyl
GDP + ?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1,4)Glcbeta-1-NAc
GDP + ?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1,4)Glcbeta-N3
GDP + ?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1,4)Glcbeta-O-phenyl
GDP + ?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1,4)Glcbeta-S-phenyl
GDP + ?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1,4)Man
GDP + ?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1-3)GalNAc
GDP + Fucalpha(1-2)Galbeta(1-3)GalNAc
-
-
-
-
ir
GDP-beta-L-fucose + Galbeta(1-3)GalNAc
GDP + L-Fucalpha(1-2)Galbeta(1-3)GalNAc
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1-3)GalNAcalpha-O-p-nitrophenol
GDP + Fucalpha(1-2)Galbeta(1-3)GalNAcalpha-O-p-nitrophenol
-
-
-
-
ir
GDP-beta-L-fucose + Galbeta(1-3)GalNAcalpha-OMe
GDP + Fucalpha(1-2)Galbeta(1-3)GalNAcalpha-OMe
GDP-beta-L-fucose + Galbeta(1-3)GalNAcalpha-R
GDP + Fucalpha(1-2)Galbeta(1-3)GalNAcalpha-R
-
-
-
-
ir
GDP-beta-L-fucose + Galbeta(1-3)GlcNAc
?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1-3)GlcNAcbeta(1-3)Galbeta(1-4)Glc-beta-O-PA8
?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta(1-3)GlcNAcbeta-O-p-nitrophenol
GDP + Fucalpha(1-2)Galbeta(1-3)GlcNAcbeta-O-p-nitrophenol
-
activity is low
-
-
ir
GDP-beta-L-fucose + Galbeta(1-3)[Fucalpha(1-4)]GlcNAc
GDP + Fucalpha(1-2)Galbeta(1-3)[Fucalpha(1-4)]GlcNAc
-
activity is low
-
-
ir
GDP-beta-L-fucose + Galbeta(1-3)[GlcNAcbeta(1-6)]GalNAcalpha-O-p-nitrophenol
GDP + Fucalpha(1-2)Galbeta(1-3)[GlcNAcbeta(1-6)]GalNAcalpha-O-p-nitrophenol
-
-
-
-
ir
GDP-beta-L-fucose + Galbeta(1-6)GlcNAc
?
-
-
-
-
?
GDP-beta-L-fucose + Galbeta-4-nitrophenyl
?
28% activity compared to D-lactose
-
-
?
GDP-beta-L-fucose + Galbeta-O-Me
GDP + L-Fucalpha(1-2)Galbeta-O-Me
-
-
-
-
?
GDP-beta-L-fucose + Galbeta-p-nitrophenol
GDP + L-Fucalpha(1-2)Galbeta-p-nitrophenol
-
-
-
-
?
GDP-beta-L-fucose + lacto-N-biose
?
GDP-beta-L-fucose + lactose
GDP + fucosyllactose
-
-
-
-
?
GDP-beta-L-fucose + lactose-N-biose I
?
-
-
-
-
?
GDP-beta-L-fucose + lactosylceramide
?
-
-
-
-
?
GDP-beta-L-fucose + lactulose
GDP + 2'-fucosyl-D-lactulose
-
-
-
-
?
GDP-beta-L-fucose + lactulose
GDP + ?
-
-
-
-
?
GDP-beta-L-fucose + phenyl 2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-alpha-D-galactopyranoside
GDP + phenyl L-fucosyl-alpha (1->2)-D-Gal-beta-(1->3)-alpha-D-GalNAc
-
-
-
-
?
GDP-beta-L-fucose + phenyl beta-D-galactopyranoside
GDP + phenyl alpha-L-fucosyl-(1->2)-beta-D-galactopyranoside
-
-
-
?
GDP-beta-L-fucose + phenyl beta-D-thiogalactopyranoside
GDP + phenyl L-fucosyl-alpha-(1->2)-beta-D-thiogalactopyranoside
-
-
-
-
?
GDP-fucose + asialofetuin
GDP + asialofetuin
-
-
-
-
?
GDP-fucose + Galbeta-O-Bn
GDP + L-Fucalpha(1-2)Galbeta-O-Bn
-
-
-
-
?
GDP-fucose + Galbeta1-4Glc
Fucalpha1-2Galbeta1-4Glc + GDP
-
-
-
-
?
GDP-fucose + Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc + GDP
-
-
-
-
?
GDP-L-Fuc + XLLGXLLG-2-aminopyridine
GDP + alpha-L-fucosyl-XLLGXLLG-2-aminopyridine
acceptor xyloglucan oligosaccharide carrying two repeated XLLG units plus 2-aminopyridine
-
-
?
GDP-L-fucose + 6-sulfoGalbeta(1-4)GlcNAcbeta-O-methyl
GDP + L-Fucalpha(1-2)6-sulfoGalbeta(1-4)GlcNAcbeta-O-methyl
-
-
-
-
?
GDP-L-fucose + agalacto-asialofetuin
GDP + alpha-L-fucosyl-1,2-agalacto-asialofetuin
-
-
-
-
?
GDP-L-fucose + arabinogalactan protein
?
-
isoforms FUT4.1 and FUT 6 incorporate terminal alpha-L-fucose residues on the C-2 positions of adjacent arabinose residues of arabinogalactan proteins
-
-
?
GDP-L-fucose + asialo alpha1 acid glycoprotein
GDP + alpha-L-fucosyl-1,2-asialo alpha1 acid glycoprotein
-
-
-
-
?
GDP-L-fucose + asialofetuin
GDP + alpha-L-fucosyl-1,2-asialofetuin
-
-
-
-
?
GDP-L-fucose + beta-D-galactose-beta-O-2-(2-carbomethoxyethylthio)ethyl
?
-
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
GDP-L-fucose + beta-methyl-D-galactopyranoside
GDP + alpha-L-fucosyl-1,2-beta-methyl-D-galactopyranoside
-
-
-
-
?
GDP-L-fucose + bovine IgG diantennary glycopeptide
GDP + ?
-
-
-
-
?
GDP-L-fucose + D-fucose
GDP + alpha-L-fucosyl-1,2-D-fucose
-
-
-
-
?
GDP-L-fucose + D-galactose
GDP + alpha-L-fucosyl-1,2-D-galactose
GDP-L-fucose + D-Galbeta(1-2)D-Xylalpha(1-6)D-Glcbeta(1-4)D-Glc
GDP + L-Fucalpha(1-2)-D-Galbeta1-2-D-Xylalpha1-6-D-Glcbeta1-4-D-Glc
GDP-L-fucose + di-N-acetylchitobiose
GDP + ?
-
-
-
-
?
GDP-L-fucose + fetuin
GDP + alpha-L-fucosyl-1,2-fetuin
GDP-L-fucose + fetuin triantennary asialoglycopeptide
GDP + ?
-
-
-
-
?
GDP-L-fucose + galacto-N-biose
GDP + alpha-L-fucosyl-1,2-galacto-N-biose
GDP-L-fucose + Galalpha(1-3)Galbeta(1-4)GlcNAcbeta(1-3)Galbeta(1-4)Glc-ceramide
GDP + L-Fucalpha(1-2)Galalpha(1-3)Galbeta(1-4)GlcNAcbeta(1-3)Galbeta(1-4)Glc-ceramide
-
-
-
?
GDP-L-fucose + GalalphaCH3
GDP + L-Fucalpha(1-2)GalalphaCH3
-
0.1% of the activity with Galbeta1-3GalNAc
-
-
?
GDP-L-fucose + Galbeta(1-2)D-Xyl
GDP + L-Fucalpha(1-2)D-Galbeta(1-2)D-Xyl
GDP-L-fucose + Galbeta(1-3)Ara
GDP + L-Fucalpha(1-2)Galbeta(1-3)Ara
-
3.3% of the activity with Galbeta1-3GalNAc
-
-
?
GDP-L-fucose + Galbeta(1-3)GalNAc
GDP + L-Fucalpha(1-2)Galbeta(1-3)GalNAc
GDP-L-fucose + Galbeta(1-3)GalNAcbeta(1-4)(NeuAcalpha(2-3))Galbeta(1-4)Glcbeta1-ceramide
GDP + L-Fucalpha(1-2)Galbeta(1-3)GalNAcbeta(1-4)(NeuAcalpha(2-3))Galbeta(1-4)Glcbeta1-cera mide
-
-
-
?
GDP-L-fucose + Galbeta(1-3)GalNAcbeta1-OCH2CH=CH2
GDP + L-Fucalpha(1-2)Galbeta(1-3)GalNAcbeta1-OCH2CH=CH2
-
-
-
-
?
GDP-L-fucose + Galbeta(1-3)GlcNAcbeta(1-3)Galbeta(1-4)Glc
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAcbeta(1-3)Galbeta(1-4)Glc
-
84% of the activity with Galbeta1-3GalNAc
-
-
?
GDP-L-fucose + Galbeta(1-3)GlcNAcbeta-O-allyl/acrylamide copolymer
GDP + ?
-
-
-
-
?
GDP-L-fucose + Galbeta(1-3)GlcNAcbeta-O-benzyl
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAcbeta-O-benzyl
-
-
-
-
?
GDP-L-fucose + Galbeta(1-4)Glc
GDP + L-Fucalpha(1-2)Galbeta(1-4)Glc
-
4.2% of the activity with Galbeta1-3GalNAc
-
-
?
GDP-L-fucose + Galbeta(1-4)Glc-beta-O-2-(2-carbomethoxyethylthio)ethyl
GDP + L-Fucalpha(1-2)Galbeta(1-4)Glc-beta-O-2-(2-carbomethoxyethylthio)ethyl
-
-
-
-
?
GDP-L-fucose + Galbeta(1-4)GlcNAc
GDP + L-Fucalpha(1-2)Galbeta(1-4)GlcNAc
-
7.5% of the activity with Galbeta1-3GalNAc
-
-
?
GDP-L-fucose + Galbeta(1-4)GlcNAc(1-3)Galbeta(1-4)Glc
GDP + L-Fucalpha(1-2)Galbeta(1-4)GlcNAc(1-3)Glabeta(1-4)Glc
-
2.8% of the activity with Galbeta(1-3)GalNAc
-
-
?
GDP-L-fucose + Galbeta(1-4)GlcNAc-beta-O-2-(2-carbomethoxyethylthio)ethyl
GDP + L-Fucalpha(1-2)Galbeta(1-4)Glc-beta-O-2-(2-carbomethoxyethylthio)ethyl
-
-
-
-
?
GDP-L-fucose + Galbeta(1-4)GlcNAcbeta(1-3)Galbeta(1-4)Glc-ceramide
GDP + L-Fucalpha(1-2)Galbeta(1-4)GlcNAcbeta(1-3)Galbeta(1-4)Glc-ceramide
-
-
-
-
?
GDP-L-fucose + Galbeta(1-4)GlcNAcbeta-O-benzyl
GDP + L-Fucalpha(1-2)Galbeta(1-4)GlcNAcbeta-O-benzyl
-
-
-
-
?
GDP-L-fucose + Galbeta(1-4)Man
GDP + L-Fucalpha(1-2)Galbeta(1-4)Man
-
2.7% of the activity with Galbeta1-3GalNAc
-
-
?
GDP-L-fucose + Galbeta(1-6)GalNAc
GDP + L-Fucalpha(1-2)Galbeta(1-6)GalNAc
GDP-L-fucose + Galbeta(1->3)-GalNAcalpha-OH
GDP + Fucalpha(1->2)-Galbeta(1->3)-GalNAcalpha-OH
GDP-L-fucose + Galbeta(1->3)-GalNAcalpha-OMe
GDP + Fucalpha(1->2)-Galbeta(1->3)-GalNAcalpha-OMe
GDP-L-fucose + Galbeta-O-benzyl
GDP + L-Fucalpha(1-2)Galbeta-O-benzyl
-
-
-
-
?
GDP-L-fucose + GalbetaCH3
GDP + L-Fucalpha(1-2)GalbetaCH3
-
2.6% of the activity with Galbeta1-3GalNAc
-
-
?
GDP-L-fucose + GM1
GDP + ?
-
-
-
-
?
GDP-L-fucose + GM1 ganglioside
GDP + ?
GDP-L-fucose + intestinal glycoprotein
GDP + alpha-L-fucosyl-1,2-intestinal glycoprotein
-
-
-
-
?
GDP-L-fucose + lacto-N-biose 1
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAc
GDP-L-fucose + lacto-N-fucopentaose II
GDP + ?
-
-
-
-
?
GDP-L-fucose + lacto-N-neotetraose
GDP + lacto-N-fucopentaose IV
GDP-L-fucose + lacto-N-tetraose
GDP + lacto-N-fucopentaose I
GDP-L-fucose + lactose
GDP + fucosyllactose
GDP-L-fucose + lactosylceramide
GDP + ?
-
-
-
-
?
GDP-L-fucose + N-acetylallolactosamine
GDP + ?
-
-
-
-
?
GDP-L-fucose + N-acetyllactosamine
GDP + alpha-L-fucosyl-1,2-N-acetyllactosamine
GDP-L-fucose + p-nitrophenyl beta-D-fucoside
GDP + alpha-L-fucosyl-1,2-nitrophenyl beta-D-fucoside
-
-
-
-
?
GDP-L-fucose + paragloboside
GDP + ?
-
-
-
?
GDP-L-fucose + phenyl-beta-D-galactoside
?
-
-
-
-
?
GDP-L-fucose + phenyl-beta-D-galactoside
GDP + phenyl 2-O-(alpha-L-fucopyranosyl)-beta-D-galactopyranoside
GDP-L-fucose + porcine submaxillary mucin
GDP + alpha-L-fucosyl-1,2-porcine submaxillary mucin
-
-
-
-
?
GDP-L-Gal + xyloglucan oligosaccharide
GDP + L-galactosyl-xyloglucan oligosaccharide
-
-
-
?
additional information
?
-
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosamine
residues of H type 3 epitopes, reaction of EC 2.4.1.69
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosamine
residues of H type 3 epitopes
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosamine
residues of H type 1 epitopes, reaction of EC 2.4.1.69
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosamine
residues of H type 1 epitopes
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
-
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
-
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
-
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine
-
i.e. lacto-N-biose I
-
-
?
GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine
GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine
-
i.e. lacto-N-biose I, reaction of EC 2.4.1.69
82% of the activity with phenyl beta-D-galactopyranoside
-
?
GDP-beta-L-fucose + D-galactose
?
70% activity compared to D-lactose
-
-
?
GDP-beta-L-fucose + D-galactose
?
70% activity compared to D-lactose
-
-
?
GDP-beta-L-fucose + D-lactose
GDP + 2'-fucosyl-D-lactose
100% activity
-
-
?
GDP-beta-L-fucose + D-lactose
GDP + 2'-fucosyl-D-lactose
100% activity
-
-
?
GDP-beta-L-fucose + D-lactulose
GDP + 2'-fucosyl-D-lactulose
125% activity compared to D-lactose
-
-
?
GDP-beta-L-fucose + D-lactulose
GDP + 2'-fucosyl-D-lactulose
125% activity compared to D-lactose
-
-
?
GDP-beta-L-fucose + Gal-beta-OR
GDP + L-Fucalpha(1-2)Galbeta-OR
Q5JBG3
-
-
-
ir
GDP-beta-L-fucose + Gal-beta-OR
GDP + L-Fucalpha(1-2)Galbeta-OR
Q5JBG3
-
-
-
ir
GDP-beta-L-fucose + Galbeta(1-3)GalNAcalpha-OMe
GDP + Fucalpha(1-2)Galbeta(1-3)GalNAcalpha-OMe
Q5JBG3
-
-
-
ir
GDP-beta-L-fucose + Galbeta(1-3)GalNAcalpha-OMe
GDP + Fucalpha(1-2)Galbeta(1-3)GalNAcalpha-OMe
Q5JBG3
-
-
-
ir
GDP-beta-L-fucose + lacto-N-biose
?
-
-
-
-
?
GDP-beta-L-fucose + lacto-N-biose
?
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
fut1, fut2, and sec1 genes encode proteins that only can alpha1,2-fucosylate type 3/4, GM1 and galacto-N-biose acceptors
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
349720, 489348, 489349, 489350, 489351, 489352, 489358, 489359, 489360, 489361, 489365 -
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
the enzyme transfers fucose equally well to Galbeta(1-3)GlcNAc type and Galbeta(1-4)GlcNAc type substrates. Galbeta1-3GalNAc structures are less efficient acceptors
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
acceptor specificity, overview. C6-sulfation of terminal Gal in the LacNAc unit increases acceptor efficiency, C-6 sialylation abolishes acceptor ability, C6-sulfation of GlcNAc in LacNAc type 2 decreases by 80% the acceptor ability, whereas LacNAc type 1 is unaffected, the C-4 hydroxyl rather than the C-6 hydroxyl group of the GlcNAc moiety in LacNAc type 1 is essential for activity, the acrylamide copolymer of Galbeta(1-3)GlcNAcbeta-O-Al is the best acceptor among the acrylamide copolymers, Lewis x does not serve as an acceptor
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
detailed characterization of specificity
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
the acid form of the enzyme is probably involved in glycoprotein synthesis in vivo
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
fucosyltransferase 1 may contribute to pathological prostatic growth
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
enzyme is involved in expression of blood group H, Lewis b from Lewis a and Globo H
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
the galactoside 2-alpha-L-fucosyltransferase gene determines the expression of terminal L-Fucalpha(1-2)Galbeta epitopes
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
fucosyltransferase 1 may contribute to pathological prostatic growth
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
the enzyme forms the Fuc(1-2)Gal linkage with oligosaccharides, glycoproteins, and glycolipids which contain nonreducing terminal galactose residues and shows no absolute specificity for a particular penultimate residue or for the linkage between the galactose and the penultimate residue. The enzyme fucosylates human Bombay" erythrocytes which lack cell surface Fucalpha1-2Gal structures
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
the enzyme forms exclusively L-Fucalpha(1-2)Gal linkage with a variety of acceptor substrates
-
-
?
GDP-L-fucose + beta-D-galactosyl-R
GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R
-
-
-
-
?
GDP-L-fucose + D-galactose
GDP + alpha-L-fucosyl-1,2-D-galactose
-
-
-
?
GDP-L-fucose + D-galactose
GDP + alpha-L-fucosyl-1,2-D-galactose
-
-
-
-
?
GDP-L-fucose + D-galactose
GDP + alpha-L-fucosyl-1,2-D-galactose
-
-
-
?
GDP-L-fucose + D-galactose
GDP + alpha-L-fucosyl-1,2-D-galactose
-
-
-
-
?
GDP-L-fucose + D-Galbeta(1-2)D-Xylalpha(1-6)D-Glcbeta(1-4)D-Glc
GDP + L-Fucalpha(1-2)-D-Galbeta1-2-D-Xylalpha1-6-D-Glcbeta1-4-D-Glc
-
-
-
?
GDP-L-fucose + D-Galbeta(1-2)D-Xylalpha(1-6)D-Glcbeta(1-4)D-Glc
GDP + L-Fucalpha(1-2)-D-Galbeta1-2-D-Xylalpha1-6-D-Glcbeta1-4-D-Glc
-
-
-
?
GDP-L-fucose + D-Galbeta(1-2)D-Xylalpha(1-6)D-Glcbeta(1-4)D-Glc
GDP + L-Fucalpha(1-2)-D-Galbeta1-2-D-Xylalpha1-6-D-Glcbeta1-4-D-Glc
-
-
-
?
GDP-L-fucose + D-Galbeta(1-2)D-Xylalpha(1-6)D-Glcbeta(1-4)D-Glc
GDP + L-Fucalpha(1-2)-D-Galbeta1-2-D-Xylalpha1-6-D-Glcbeta1-4-D-Glc
-
-
-
?
GDP-L-fucose + fetuin
GDP + alpha-L-fucosyl-1,2-fetuin
-
-
-
-
?
GDP-L-fucose + fetuin
GDP + alpha-L-fucosyl-1,2-fetuin
-
-
-
-
?
GDP-L-fucose + galacto-N-biose
GDP + alpha-L-fucosyl-1,2-galacto-N-biose
-
-
-
?
GDP-L-fucose + galacto-N-biose
GDP + alpha-L-fucosyl-1,2-galacto-N-biose
-
-
-
?
GDP-L-fucose + Galbeta(1-2)D-Xyl
GDP + L-Fucalpha(1-2)D-Galbeta(1-2)D-Xyl
-
-
-
?
GDP-L-fucose + Galbeta(1-2)D-Xyl
GDP + L-Fucalpha(1-2)D-Galbeta(1-2)D-Xyl
-
-
-
?
GDP-L-fucose + Galbeta(1-2)D-Xyl
GDP + L-Fucalpha(1-2)D-Galbeta(1-2)D-Xyl
-
-
-
?
GDP-L-fucose + Galbeta(1-2)D-Xyl
GDP + L-Fucalpha(1-2)D-Galbeta(1-2)D-Xyl
-
-
-
?
GDP-L-fucose + Galbeta(1-3)GalNAc
GDP + L-Fucalpha(1-2)Galbeta(1-3)GalNAc
-
-
-
-
?
GDP-L-fucose + Galbeta(1-3)GalNAc
GDP + L-Fucalpha(1-2)Galbeta(1-3)GalNAc
-
-
-
-
?
GDP-L-fucose + Galbeta(1-3)GalNAc
GDP + L-Fucalpha(1-2)Galbeta(1-3)GalNAc
-
-
-
-
?
GDP-L-fucose + Galbeta(1-6)GalNAc
GDP + L-Fucalpha(1-2)Galbeta(1-6)GalNAc
-
-
-
-
?
GDP-L-fucose + Galbeta(1-6)GalNAc
GDP + L-Fucalpha(1-2)Galbeta(1-6)GalNAc
-
4.8% of the activity with Galbeta1-3GalNAc
-
-
?
GDP-L-fucose + Galbeta(1->3)-GalNAcalpha-OH
GDP + Fucalpha(1->2)-Galbeta(1->3)-GalNAcalpha-OH
-
-
-
?
GDP-L-fucose + Galbeta(1->3)-GalNAcalpha-OH
GDP + Fucalpha(1->2)-Galbeta(1->3)-GalNAcalpha-OH
-
-
-
?
GDP-L-fucose + Galbeta(1->3)-GalNAcalpha-OMe
GDP + Fucalpha(1->2)-Galbeta(1->3)-GalNAcalpha-OMe
highest activity
-
-
?
GDP-L-fucose + Galbeta(1->3)-GalNAcalpha-OMe
GDP + Fucalpha(1->2)-Galbeta(1->3)-GalNAcalpha-OMe
highest activity
-
-
?
GDP-L-fucose + GM1 ganglioside
GDP + ?
-
-
-
-
?
GDP-L-fucose + GM1 ganglioside
GDP + ?
-
-
-
?
GDP-L-fucose + lacto-N-biose 1
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAc
-
-
-
?
GDP-L-fucose + lacto-N-biose 1
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAc
-
-
-
-
?
GDP-L-fucose + lacto-N-biose 1
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAc
-
i.e. Gal(1-3)GlcNAc
-
-
?
GDP-L-fucose + lacto-N-biose 1
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAc
-
-
-
-
?
GDP-L-fucose + lacto-N-biose 1
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAc
-
-
-
-
?
GDP-L-fucose + lacto-N-biose 1
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAc
-
-
-
?
GDP-L-fucose + lacto-N-biose 1
GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAc
-
-
-
-
?
GDP-L-fucose + lacto-N-neotetraose
GDP + lacto-N-fucopentaose IV
-
-
-
-
?
GDP-L-fucose + lacto-N-neotetraose
GDP + lacto-N-fucopentaose IV
-
-
-
?
GDP-L-fucose + lacto-N-neotetraose
GDP + lacto-N-fucopentaose IV
-
-
-
-
?
GDP-L-fucose + lacto-N-tetraose
GDP + lacto-N-fucopentaose I
-
-
-
-
?
GDP-L-fucose + lacto-N-tetraose
GDP + lacto-N-fucopentaose I
-
-
-
?
GDP-L-fucose + lacto-N-tetraose
GDP + lacto-N-fucopentaose I
-
-
-
?
GDP-L-fucose + lactose
GDP + fucosyllactose
-
-
-
?
GDP-L-fucose + lactose
GDP + fucosyllactose
-
-
-
?
GDP-L-fucose + lactose
GDP + fucosyllactose
-
-
-
-
?
GDP-L-fucose + lactose
GDP + fucosyllactose
-
-
2'-fucosyllactose
?
GDP-L-fucose + lactose
GDP + fucosyllactose
-
-
-
-
?
GDP-L-fucose + lactose
GDP + fucosyllactose
-
-
-
-
?
GDP-L-fucose + N-acetyllactosamine
GDP + alpha-L-fucosyl-1,2-N-acetyllactosamine
-
-
-
-
?
GDP-L-fucose + N-acetyllactosamine
GDP + alpha-L-fucosyl-1,2-N-acetyllactosamine
-
-
-
-
?
GDP-L-fucose + N-acetyllactosamine
GDP + alpha-L-fucosyl-1,2-N-acetyllactosamine
-
-
-
-
?
GDP-L-fucose + N-acetyllactosamine
GDP + alpha-L-fucosyl-1,2-N-acetyllactosamine
-
-
-
?
GDP-L-fucose + phenyl-beta-D-galactoside
GDP + phenyl 2-O-(alpha-L-fucopyranosyl)-beta-D-galactopyranoside
-
-
-
-
?
GDP-L-fucose + phenyl-beta-D-galactoside
GDP + phenyl 2-O-(alpha-L-fucopyranosyl)-beta-D-galactopyranoside
-
-
-
?
GDP-L-fucose + phenyl-beta-D-galactoside
GDP + phenyl 2-O-(alpha-L-fucopyranosyl)-beta-D-galactopyranoside
-
-
-
-
?
GDP-L-fucose + phenyl-beta-D-galactoside
GDP + phenyl 2-O-(alpha-L-fucopyranosyl)-beta-D-galactopyranoside
-
-
-
-
?
GDP-L-fucose + phenyl-beta-D-galactoside
GDP + phenyl 2-O-(alpha-L-fucopyranosyl)-beta-D-galactopyranoside
-
-
-
-
?
GDP-L-fucose + phenyl-beta-D-galactoside
GDP + phenyl 2-O-(alpha-L-fucopyranosyl)-beta-D-galactopyranoside
-
-
-
?
additional information
?
-
-
dearabinosylated arabinogalactan proteins are not substrate acceptors for isoforms FUT4.1 and FUT6
-
-
?
additional information
?
-
recombinant FUT1 catalyzes L-Gal transfer to xyloglucan oligosaccharides with an initial velocity of L-Gal transfer 3.1 times lower than that of L-Fuc transfer. No acceptor: mono-D-galactosylated xyloglucan oligosaccharide XXLG-2-aminopyridine, XLLG-2-aminopyridine
-
-
-
additional information
?
-
the enzyme displays strict substrate specificity, displaying activity only towards acceptors that contain Gal-beta(1->3)-GalNAc-apha-OR linkages and does not recognize lactose, lactulose, Gal-alpha(1->3)-Gal-beta(1->4)Glc, alpha-GalGal-beta(1->4)-glucitol, and beta-D-Gal as acceptors
-
-
?
additional information
?
-
no activity with D-galactosamine, N-acetyl-D-galactosamine, Gal(beta1-4)Glcbeta1-Bn, Gal(beta1-4)Glcbeta1-octyl, Gal(beta1-4)[Fuc(alpha1-3)]Glc, Gal(beta1-4)GlcNAc(beta1-3)Gal(beta1-4)GlcNAcbeta-linker-tBoc, and Gal(alpha1-6)Glc(alpha1-2)Fru
-
-
?
additional information
?
-
no activity with D-galactosamine, N-acetyl-D-galactosamine, Gal(beta1-4)Glcbeta1-Bn, Gal(beta1-4)Glcbeta1-octyl, Gal(beta1-4)[Fuc(alpha1-3)]Glc, Gal(beta1-4)GlcNAc(beta1-3)Gal(beta1-4)GlcNAcbeta-linker-tBoc, and Gal(alpha1-6)Glc(alpha1-2)Fru
-
-
?
additional information
?
-
the enzyme displays strict substrate specificity, displaying activity only towards acceptors that contain Gal-beta(1->3)-GalNAc-apha-OR linkages and does not recognize lactose, lactulose, Gal-alpha(1->3)-Gal-beta(1->4)Glc, alpha-GalGal-beta(1->4)-glucitol, and beta-D-Gal as acceptors
-
-
?
additional information
?
-
-
secretor-type alpha1-2 fucosyltransferase shows significant lower affinity than the H-gene encoded enzyme for phenyl-beta-D-galactopyranoside and GDP-L-fucose as well as for type 1 oligosaccharide acceptors, Galbeta1-4GlcNAc. Type 1 acceptors, Galbeta1-3GlcNAc, and type 3 acceptors, Galbeta1-3GalNAc, are preferentially used by the secretor-type enzyme as compared with the H enzyme
-
-
?
additional information
?
-
-
enzyme favors certain glycoproteins containing polylactosamine units
-
-
?
additional information
?
-
-
alpha-galactosidase and alpha-1,2-fucosyltransferase can inhibit the expression of Gal-alpha-1,3-Gal synergistically, leading to stronger resistance of xenograft against cytolysis mediated by natural antibodies and complements
-
-
?
additional information
?
-
-
FUT1 is able to efficiently alpha(1,2)-fucosylate the O-linked glycans of PSGL-1 but not the sLex structures that bind too the P-selectin
-
-
?
additional information
?
-
transfection of the mouse Fut1 and Fut2, and human FUT1 genes into human ovarian carcinoma-derived RMG-1 cells results in 2030fold increases in cellular alpha1,2-fucosyltransferase activity, and in alteration of the glycolipid composition, including not only fucosylated products, but also precursor glycolipids
-
-
?
additional information
?
-
-
transfection of the mouse Fut1 and Fut2, and human FUT1 genes into human ovarian carcinoma-derived RMG-1 cells results in 2030fold increases in cellular alpha1,2-fucosyltransferase activity, and in alteration of the glycolipid composition, including not only fucosylated products, but also precursor glycolipids
-
-
?
additional information
?
-
-
the enzyme reduces terminal alpha(2,3)-sialylation in transfected cells and transgenic animals
-
-
?
additional information
?
-
-
FUT2 directs alpha2-fucosylation on type 1 chains on both N- and O-linked glycan structures
-
-
?
additional information
?
-
-
FUT2 regulates the expression of a carbohydrate on the gastrointestinal epitheliumstrong association is observed between the nonsense mutation 428G--A in the FUT2 gene and a slow disease progression of HIV-1 infection
-
-
?
additional information
?
-
-
FutC substrates are generated by both FutA and FutB, and their heptad repeat number correlates to Lewis y O-antigen polymer sizes
-
-
?
additional information
?
-
-
human secretor FUT2 gene, which codes for an alph(1,2)-fucosyltransferase synthesizing the H-type 1 antigen in saliva and mucosa, is associated with susceptibility to norovirus infections. the FUT2 nonsecretor (se428se428) genotype is associated with resistance to nosocomial and sporadic outbreaks with norovirus
-
-
?
additional information
?
-
-
enzyme accepts both precursors of type 1 and type 2 H epitopes, catalyzing reactions of EC 2.4.1.69 and EC 2.4.1.344. The enzyme does not display alpha-(1,3)-fucosyltransferase activity or alpha-(1, 4)-fucosyl transferase activity
-
-
?
additional information
?
-
-
the enzyme transfers fucose equally well to type I (Galbeta-(1->3)-GIcNAc) and type 2 (Galbeta-(1->4)-GIcNAc) substrates, reaction of EC 2.4.1.344, but type 3 (Galbeta-(1->3)-GalNAc) structures are less efficient acceptors
-
-
?
additional information
?
-
P97327
transfection of the mouse Fut1 and Fut2, and human FUT1 genes into human ovarian carcinoma-derived RMG-1 cells results in 2030fold increases in cellular alpha1,2-fucosyltransferase activity, and in alteration of the glycolipid composition, including not only fucosylated products, but also precursor glycolipids
-
-
?
additional information
?
-
transfection of the mouse Fut1 and Fut2, and human FUT1 genes into human ovarian carcinoma-derived RMG-1 cells results in 2030fold increases in cellular alpha1,2-fucosyltransferase activity, and in alteration of the glycolipid composition, including not only fucosylated products, but also precursor glycolipids
-
-
?
additional information
?
-
-
transfection of the mouse Fut1 and Fut2, and human FUT1 genes into human ovarian carcinoma-derived RMG-1 cells results in 2030fold increases in cellular alpha1,2-fucosyltransferase activity, and in alteration of the glycolipid composition, including not only fucosylated products, but also precursor glycolipids
-
-
?
additional information
?
-
the enzyme shows a strong preference for terminal Galbeta1, 3GalNAc structures
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Scudder, P.R.; Chantler, E.N.
Glycosyltransferases of the human cervical epithelium. I. Characterization of a beta-galactoside alpha-2-L-fucosyltransferase and the identification of a beta-N-acetylglucosaminide alpha-3-L-fucosyltransferase
Biochim. Biophys. Acta
660
128-135
1981
Homo sapiens
brenda
Beyer, T.A.; Sadler, J.E.; Hill, R.L.
Purification to homogeneity of H blood group beta-galactoside alpha 1->2 fucosyltransferase from porcine submaxillary gland
J. Biol. Chem.
255
5364-5372
1980
Sus scrofa
brenda
Beyer, T.A.; Hill, R.L.
Enzymatic properties of the beta-galactoside alpha 1->2 fucosyltransferase from porcine submaxillary gland
J. Biol. Chem.
255
5373-5379
1980
Sus scrofa
brenda
Barreaud, J.P.; Saunier, K.; Souchaire, J.; Delourme, D.; Oulmouden, A.; Oriol, R.; Leveziel, H.; Julien, R.; Petit, J.M.
Three bovine alpha2-fucosyltransferase genes encode enzymes that preferentially transfer fucose on Galbeta1-3GalNAc acceptor substrates
Glycobiology
10
611-621
2000
Bos taurus (Q28113), Bos taurus
brenda
Kyprianou, P.; Betteridge, A.; Donald, A.S.R.; Watkins, W.M.
Purification of the blood group H gene associated alpha-2-L-fucosyltransferase from human plasma
Glycoconjugate J.
7
573-588
1990
Homo sapiens
brenda
Basu, S.; Basu, M.; Chien, J.L.
Enzymatic synthesis of a blood group H-related glycosphingolipid by an alpha-fucosyltransferase from bovine spleen
J. Biol. Chem.
250
2956-2962
1975
Bos taurus
brenda
Grollman, A.P.
GDP-L-fucose:lactose fucosyltransferase from mammary gland
Methods Enzymol.
8
351-353
1966
Canis lupus familiaris
-
brenda
Chester, M.A.; Yates, A.D.; Watkins, W.M.
Phenyl beta-D-galactosylpyranoside as an acceptor substrate for the blood-group H gene-associated guanosine diphosphate L-fucose:beta-D-galactosyl alpha-2-L-fucosyltransferase
Eur. J. Biochem.
69
583-592
1976
Homo sapiens
-
brenda
Sarnesto, A.; Koehlin, T.; Thurin, J.; Blaszczyk-Thurin, M.
Purification of Hgene-encoded beta-galactoside alpha 1->2 fucosyltransferase from human serum
J. Biol. Chem.
265
15067-15075
1990
Homo sapiens
brenda
Sarnesto, A.; Koehlin, T.; Hindsgaul, O.; Thurin, J.; Blaszczyk-Thurin, M.
Purification of the secretor-type beta-galactoside alpha 1->2-fucosyltransferase from human serum
J. Biol. Chem.
267
2737-2744
1992
Homo sapiens
brenda
Pacuszka, T.; Koscielak, J.
alpha 1->2 Fucosyltransferase of human bone marrow
FEBS Lett.
41
348-351
1974
Homo sapiens
brenda
Chou, T.H.; Murphy, C.; Kessel, D.
Selective inhibition of a plasma fucosyltransferase by N-ethylmaleimide
Biochem. Biophys. Res. Commun.
74
1001-1006
1977
Homo sapiens
brenda
Bella, A.; Kim, Y.S.
Biosynthesis of intestinal glycoprotein: a study of an (1 lead to 2) fucosyltransferase in rat small intestinal mucosa
Arch. Biochem. Biophys.
147
753-761
1971
Rattus norvegicus
brenda
Bella, A.; Kim, Y.S.
Inhibition of rat small-intestinal alpha-(1-> 2)-fucosyltransferase
Biochem. J.
125
1157-1158
1971
Rattus norvegicus
brenda
Thurin, J.; Blaszczyk-Thurin, M.
Porcine submaxillary gland GDP-L-fucose: beta-D-galactoside alpha-2-L-fucosyltransferase is likely a counterpart of the human Secretor gene-encoded blood group transferase
J. Biol. Chem.
270
26577-26580
1995
Sus scrofa
brenda
Sherwood, A.L.; Stroud, M.R.; Levery, S.B.; Holmes, E.H.
An amino acid region at the N-terminus of rat hepatoma alpha1->2 fucosyltransferase modulates enzyme activity and interaction with lipids: strong preference for glycosphingolipids containing terminal Galbeta1->3GalNAc-structures
Biochemistry
40
5708-5719
2001
Rattus norvegicus (Q10984)
brenda
Prieto, P.A.; Larsen, R.D.; Cho, M.; Rivera, H.N.; Shilatifard, A.; Lowe, J.B.; Cummings, R.D.; Smith, D.F.
Expression of human H-type alpha1,2-fucosyltransferase encoding for blood group H(O) antigen in Chinese hamster ovary cells. Evidence for preferential fucosylation and truncation of polylactosamine sequences
J. Biol. Chem.
272
2089-2097
1997
Homo sapiens
brenda
Domino, S.E.; Hiraiwa, N.; Lowe, J.B.
Molecular cloning, chromosomal assignment and tissue-specific expression of a murine alpha-(1,2)fucosyltransferase expressed in thymic and epididymal epithelial cells
Biochem. J.
327
105-115
1997
Homo sapiens, Mus musculus
-
brenda
Masutani, H.; Kimura, H.
Purification and characterization of secretory-type GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase from human gastric mucosa
J. Biochem.
118
541-545
1995
Homo sapiens
brenda
Marker, P.C.; Stephan, J.P.; Lee, J.; Bald, L.; Mather, J.P.; Cunha, G.R.
Fucosyltransferase1 and H-type complex carbohydrates modulate epithelial cell proliferation during prostatic branching morphogenesis
Dev. Biol.
233
95-108
2001
Homo sapiens, Rattus norvegicus
brenda
Karaivanova, V.; Mookerjea, S.; Hunt, D.; Nagpurkar, A.
Characterization and purification of fucosyltransferases from the cytosol of rat colon
Int. J. Biochem. Cell Biol.
28
165-174
1996
Rattus norvegicus
brenda
Chandrasekaran, E.V.; Chawda, R.; Locke, R.D.; Piskorz, C.F.; Matta, K.L.
Biosynthesis of the carbohydrate antigenic determinants, Globo H, blood group H, and Lewis b: a role for prostate cancer cell alpha1,2-L-fucosyltransferase
Glycobiology
12
153-162
2002
Homo sapiens
brenda
Trinchera, M.; Bozzaro, S.
Dictyostelium cytosolic fucosyltransferase synthesizes H type 1 trisaccharide in vitro
FEBS Lett.
395
68-72
1996
Dictyostelium discoideum
brenda
Koda, Y.; Soejima, M.; Kimura, H.
Changing transcription start sites in H-type alpha(1,2)fucosyltransferase gene (FUT1) during differentiation of the human erythroid lineage
Eur. J. Biochem.
256
379-387
1998
Homo sapiens
brenda
Mulder, H.; Schachter, H.; Thomas, J.R.; Halkes, K.M.; Kamerling, J.P.; Vliegenthart, J.F.
Identification of a GDP-Fuc:Gal beta 1-3GalNAc-R (Fuc to Gal) alpha 1-2 fucosyltransferase and a GDP-Fuc:Gal beta 1-4GlcNAc (Fuc to GlcNAc) alpha 1-3 fucosyltransferase in connective tissue of the snail Lymnaea stagnalis
Glycoconjugate J.
13
107-113
1996
Lymnaea stagnalis
brenda
Druzhinina, T.N.; Sizova, O.V.; Shibaev, V.N.
Fucosylation of synthetic oligosaccharides - plant xyloglucan fragments - by mammalian and amphibian fucosyltransferases
Biochemistry (Moscow)
62
62-65
1997
Rana temporaria, Rattus norvegicus, Sus scrofa, Xenopus laevis
brenda
Chandrasekaran, E.V.; Jain, R.K.; Larsen, R.D.; Wlasichuk, K.; Matta, K.L.
Characterization of the specificities of human blood group H gene-specified alpha1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between alpha1,2-L-fucosylation of Gal and alpha1,6-L-fucosylation of asparagine-linked GlcNAc
Biochemistry
35
8914-8924
1996
Homo sapiens
brenda
Bureau, V.; Marionneau, S.; Cailleau-Thomas, A.; Le Moullac-Vaidye, B.; Liehr, T.; Le Pendu, J.
Comparison of the three rat GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferases FTA, FTB and FTC
Eur. J. Biochem.
268
1006-1019
2001
Rattus norvegicus, Rattus norvegicus (Q10980), Rattus norvegicus (Q10984)
brenda
Yan, J.L.; Yu, L.Y.; Guo, L.H.
Human alpha galactosidase and alpha 1,2 fucosyltransferase concordantly inhibit xenoreactivity of NIH 3T3 cells with human serum
Acta Pharmacol. Sin.
24
878-884
2003
Homo sapiens
brenda
Mathieu, S.; Prorok, M.; Benoliel, A.M.; Uch, R.; Langlet, C.; Bongrand, P.; Gerolami, R.; El-Battari, A.
Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin
Am. J. Pathol.
164
371-383
2004
Homo sapiens
brenda
Serpa, J.; Mendes, N.; Reis, C.A.; Santos Silva, L.F.; Almeida, R.; Le Pendu, J.; David, L.
Two new FUT2 (fucosyltransferase 2 gene) missense polymorphisms, 739G-->A and 839T-->C, are partly responsible for non-secretor status in a Caucasian population from Northern Portugal
Biochem. J.
383
469-474
2004
Homo sapiens
brenda
Iwamori, M.; Tanaka, K.; Kubushiro, K.; Lin, B.; Kiguchi, K.; Ishiwata, I.; Tsukazaki, K.; Nozawa, S.
Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the alpha1,2-fucosyltransferase gene
Cancer Sci.
96
26-30
2005
Homo sapiens (P19526), Homo sapiens, Mus musculus (P97327), Mus musculus (Q9JL27), Mus musculus
brenda
Shao, J.; Li, M.; Jia, Q.; Lu, Y.; Wang, P.G.
Sequence of Escherichia coli O128 antigen biosynthesis cluster and functional identification of an alpha-1,2-fucosyltransferase
FEBS Lett.
553
99-103
2003
Escherichia coli (Q6XQ53), Escherichia coli
brenda
Sepp, A.; Skacel, P.; Lindstedt, T.; Lechler, R.I.
Expression of alpha(1,3)galactose and other type 2 oligosaccharide structures in a porcine endothelial cell line transfected with human alpha(1,2)-fucosyltransferase cDNA
J. Biol. Chem.
272
23104-23110
1997
Homo sapiens
brenda
Kindberg, E.; Hejdeman, B.; Bratt, G.; Wahren, B.; Lindblom, B.; Hinkula, J.; Svensson, L.
A nonsense mutation (428G-->A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection
AIDS
20
685-689
2006
Homo sapiens
brenda
Drouillard, S.; Driguez, H.; Samain, E.
Large-scale synthesis of H-antigen oligosaccharides by expressing Helicobacter pylori alpha1,2-fucosyltransferase in metabolically engineered Escherichia coli cells
Angew. Chem.
45
1778-1780
2006
Helicobacter pylori
brenda
Park, K.U.; Song, J.; Han, K.S.; Kim, J.Q.
The fusion allele of the FUT2 (secretor type alpha(1,2)-fucosyltransferase) gene at a high frequency and a new se385 allele in a Korean population
Ann. Hematol.
84
656-660
2005
Homo sapiens
brenda
Scheppokat, A.M.; Bretting, H.; Thiem, J.
Fast and efficient synthesis of a novel homologous series of L-fucosylated trisaccharides using the Helix pomatia alpha-(1->2)-L-galactosyltransferase
Carbohydr. Res.
338
2083-2090
2003
Helix pomatia
brenda
Holgersson, J.; Loefling, J.
Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity
Glycobiology
16
584-593
2006
Homo sapiens
brenda
Chandrasekaran, E.V.; Xue, J.; Piskorz, C.; Locke, R.D.; Toth, K.; Slocum, H.K.; Matta, K.L.
Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of alpha1,2-fucosyltransferase activities
J. Cancer Res. Clin. Oncol.
133
599-611
2007
Homo sapiens
brenda
Thorven, M.; Grahn, A.; Hedlund, K.O.; Johansson, H.; Wahlfrid, C.; Larson, G.; Svensson, L.
A homozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections
J. Virol.
79
15351-15355
2005
Homo sapiens
brenda
Nilsson, C.; Skoglund, A.; Moran, A.P.; Annuk, H.; Engstrand, L.; Normark, S.
An enzymatic ruler modulates Lewis antigen glycosylation of Helicobacter pylori LPS during persistent infection
Proc. Natl. Acad. Sci. USA
103
2863-2868
2006
Homo sapiens
brenda
Meng, D.; Newburg, D.S.; Young, C.; Baker, A.; Tonkonogy, S.L.; Sartor, R.B.; Walker, W.A.; Nanthakumar, N.N.
Bacterial symbionts induce a FUT2-dependent fucosylated niche on colonic epithelium via ERK and JNK signaling
Am. J. Physiol. Gastrointest. Liver Physiol.
293
G780-G787
2007
Homo sapiens
brenda
Soejima, M.; Koda, Y.
Distinct single nucleotide polymorphism pattern at the FUT2 promoter among human populations
Ann. Hematol.
87
19-25
2008
Homo sapiens
brenda
Li, M.; Liu, X.W.; Shao, J.; Shen, J.; Jia, Q.; Yi, W.; Song, J.K.; Woodward, R.; Chow, C.S.; Wang, P.G.
Characterization of a novel alpha1,2-fucosyltransferase of Escherichia coli O128:b12 and functional investigation of its common motif
Biochemistry
47
378-387
2008
Escherichia coli
brenda
Mathieu, S.; Gerolami, R.; Luis, J.; Carmona, S.; Kol, O.; Crescence, L.; Garcia, S.; Borentain, P.; El-Battari, A.
Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth
Int. J. Cancer
121
1680-1689
2007
Homo sapiens
brenda
Moehler, T.M.; Sauer, S.; Witzel, M.; Andrulis, M.; Garcia-Vallejo, J.J.; Grobholz, R.; Willhauck-Fleckenstein, M.; Greiner, A.; Goldschmidt, H.; Schwartz-Albiez, R.
Involvement of alpha 1-2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell-cell contacts during angiogenesis
J. Cell. Physiol.
215
27-36
2008
Homo sapiens
brenda
Yip, S.P.; Lai, S.K.; Wong, M.L.
Systematic sequence analysis of the human fucosyltransferase 2 (FUT2) gene identifies novel sequence variations and alleles
Transfusion
47
1369-1380
2007
Homo sapiens (Q10981), Homo sapiens
brenda
Li, M.; Shen, J.; Liu, X.; Shao, J.; Yi, W.; Chow, C.S.; Wang, P.G.
Identification of a new alpha1,2-fucosyltransferase involved in O-antigen biosynthesis of Escherichia coli O86:B7 and formation of H-type 3 blood group antigen
Biochemistry
47
11590-11597
2008
Escherichia coli, Escherichia coli (Q5JBG3), Escherichia coli O86:B7, Escherichia coli O86:B7 (Q5JBG3)
brenda
Zheng, Q.; Van Die, I.; Cummings, R.D.
A novel alpha1,2-fucosyltransferase (CE2FT-2) in Caenorhabditis elegans generates H-type 3 glycan structures
Glycobiology
18
290-302
2008
Caenorhabditis elegans
brenda
Silva, L.M.; Carvalho, A.S.; Guillon, P.; Seixas, S.; Azevedo, M.; Almeida, R.; Ruvoen-Clouet, N.; Reis, C.A.; Le Pendu, J.; Rocha, J.; David, L.
Infection-associated FUT2 (Fucosyltransferase 2) genetic variation and impact on functionality assessed by in vivo studies
Glycoconj. J.
27
61-68
2010
Homo sapiens
brenda
Wang, Z.A.; van der Wel, H.; Vohra, Y.; Buskas, T.; Boons, G.J.; West, C.M.
Role of a cytoplasmic dual-function glycosyltransferase in O2 regulation of development in Dictyostelium
J. Biol. Chem.
284
28896-28904
2009
Dictyostelium discoideum
brenda
Abrantes, J.; Posada, D.; Guillon, P.; Esteves, P.J.; Le Pendu, J.
Widespread gene conversion of alpha-2-fucosyltransferase genes in mammals
J. Mol. Evol.
69
22-31
2009
Chlorocebus sabaeus, Chlorocebus sabaeus (O77711), Chlorocebus sabaeus (O77712), Monodelphis domestica, Xenopus tropicalis, Bos taurus (A4IFH1), Bos taurus (Q28113), Bos taurus (Q9TTY3), Mus musculus (O09160), Mus musculus (P97353), Pan troglodytes (O77485), Pan troglodytes (Q9TUD6), Gorilla gorilla (O77486), Gorilla gorilla (Q9TUD4), Pongo pygmaeus (O77487), Pongo pygmaeus (Q6LA45), Homo sapiens (P19526), Homo sapiens (Q10981), Homo sapiens (Q5XLR8), Homo sapiens, Oryctolagus cuniculus (Q10979), Oryctolagus cuniculus (Q10983), Oryctolagus cuniculus (Q29505), Oryctolagus cuniculus, Rattus norvegicus (Q10980), Rattus norvegicus (Q10984), Rattus norvegicus (Q9WUE6), Sus scrofa (Q10982), Sus scrofa (Q29043), Hylobates agilis (Q6LA46), Macaca fascicularis (Q9N266), Hylobates lar (Q9TTC7)
brenda
Christiansen, D.; Milland, J.; Dodson, H.C.; Lazarus, B.D.; Sandrin, M.S.
The cytoplasmic and transmembrane domains of secretor type alpha1,2fucosyltransferase confer atypical cellular localisation
J. Mol. Recognit.
22
250-254
2009
Sus scrofa
brenda
Hazra, A.; Kraft, P.; Selhub, J.; Giovannucci, E.L.; Thomas, G.; Hoover, R.N.; Chanock, S.J.; Hunter, D.J.
Common variants of FUT2 are associated with plasma vitamin B12 levels
Nat. Genet.
40
1160-1162
2008
Homo sapiens (Q10981)
brenda
Carlsson, B.; Kindberg, E.; Buesa, J.; Rydell, G.E.; Lidon, M.F.; Montava, R.; Abu Mallouh, R.; Grahn, A.; Rodriguez-Diaz, J.; Bellido, J.; Arnedo, A.; Larson, G.; Svensson, L.
The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection
PLoS ONE
4
e5593
2009
Homo sapiens (Q10981)
brenda
Pettit, N.; Styslinger, T.; Mei, Z.; Han, W.; Zhao, G.; Wang, P.G.
Characterization of WbiQ: An alpha1->2-fucosyltransferase from Escherichia coli O127:K63(B8), and synthesis of H-type 3 blood group antigen
Biochem. Biophys. Res. Commun.
402
190-195
2010
Escherichia coli (Q5J7C6), Escherichia coli O127:K63(B8) (Q5J7C6)
brenda
Jasper, M.J.; Care, A.S.; Sullivan, B.; Ingman, W.V.; Aplin, J.D.; Robertson, S.A.
Macrophage-derived LIF and IL1B regulate alpha(1,2)fucosyltransferase 2 (Fut2) expression in mouse uterine epithelial cells during early pregnancy
Biol. Reprod.
84
179-188
2011
Mus musculus
brenda
Wu, Y.; Williams, M.; Bernard, S.; Driouich, A.; Showalter, A.; Faik, A.
Functional identification of two nonredundant Arabidopsis alpha(1,2)fucosyltransferases specific to arabinogalactan proteins
J. Biol. Chem.
285
13638-13645
2010
Arabidopsis thaliana
brenda
Tao, S.; He, Y.; Ying, Y.; Hong, X.; Xu, X.; Zhu, F.; Lv, H.; Yan, L.
C35T mutation could slightly decrease the activity of human alpha-(1,2)-fucosyltransferase
Transfus. Clin. Biol.
19
5-10
2012
Homo sapiens
brenda
Zeyland, J.; Wozniak, A.; Gawronska, B.; Juzwa, W.; Jura, J.; Nowak, A.; S?omski, R.; Smorag, Z.; Szalata, M.; Mazurek, U.; Lipinski, D.
Double transgenic pigs with combined expression of human alpha1,2-fucosyltransferase and alpha-galactosidase designed to avoid hyperacute xenograft rejection
Arch. Immunol. Ther. Exp.
62
411-422
2014
Homo sapiens (P19526)
brenda
Isozaki, T.; Ruth, J.H.; Amin, M.A.; Campbell, P.L.; Tsou, P.S.; Ha, C.M.; Haines, G.K.; Edhayan, G.; Koch, A.E.
Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation
Arthritis Res. Ther.
16
R28
2014
Homo sapiens (P19526)
brenda
Gao, N.; Liu, J.; Liu, D.; Hao, Y.; Yan, L.; Ma, Y.; Zhuang, H.; Hu, Z.; Gao, J.; Yang, Z.; Shi, H.; Lin, B.
c-Jun transcriptionally regulates alpha 1, 2-fucosyltransferase 1 (FUT1) in ovarian cancer
Biochimie
107 Pt B
286-292
2014
Homo sapiens (P19526)
brenda
Engels, L.; Elling, L.
WbgL: A novel bacterial alpha1,2-fucosyltransferase for the synthesis of 2-fucosyllactose
Glycobiology
24
170-178
2014
Escherichia coli (A6M9C2), Escherichia coli O126 (A6M9C2)
brenda
Che, Y.; Ren, X.; Xu, L.; Ding, X.; Zhang, X.; Sun, X.
Critical involvement of the alpha(1,2)-fucosyltransferase in multidrug resistance of human chronic myeloid leukemia
Oncol. Rep.
35
3025-3033
2016
Homo sapiens (P19526)
brenda
Dicioccio, R.A.; Barlow, J.J.; Matta, K.L.
Modified procedure for detection of GDP-L-fucose:galactoside 2-fucosyltransferase
Clin. Chim. Acta
108
41-48
1980
Homo sapiens
brenda
Kyprianou, P.; Betteridge, A.; Donald, A.S.; Watkins, W.M.
Purification of the blood group H gene associated alpha-2-L-fucosyltransferase from human plasma
Glycoconj. J.
7
573-588
1990
Homo sapiens
brenda
Ohashi, H.; Ohashi, T.; Misaki, R.; Fujiyama, K.
Arabidopsis thaliana alpha1,2-l-fucosyltransferase catalyzes the transfer of l-galactose to xyloglucan oligosaccharides
FEBS Lett.
593
187-194
2019
Arabidopsis thaliana (Q9SWH5)
brenda
Chin, Y.W.; Kim, J.Y.; Kim, J.H.; Jung, S.M.; Seo, J.H.
Improved production of 2-fucosyllactose in engineered Escherichia coli by expressing putative alpha-1,2-fucosyltransferase, WcfB from Bacteroides fragilis
J. Biotechnol.
257
192-198
2017
Bacteroides fragilis
brenda